Terms: = Thyroid cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
35 results:
1. PRMT5 methylating smad4 activates TGF-β signaling and promotes colorectal cancer metastasis.
Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
Qi F; Tang J; Cai Z; Wang G; Wang Z
Bioengineered; 2022 Mar; 13(3):7592-7606. PubMed ID: 35264071
[TBL] [Abstract] [Full Text] [Related]
3. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract] [Full Text] [Related]
4. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A; Masuda T; Iwata M; Tobo T; Wakiyama H; Koike K; Kosai K; Nakano T; Kuramitsu S; Kitagawa A; Sato K; Kouyama Y; Shimizu D; Matsumoto Y; Utsunomiya T; Ohtsuka T; Yamanishi Y; Nakamura M; Mimori K
Cancer Sci; 2021 Apr; 112(4):1655-1668. PubMed ID: 33605496
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
Pan Y; Yun W; Shi B; Cui R; Liu C; Ding Z; Fan J; Jiang W; Tang J; Zheng T; Yu X; Liu Y
J Mol Endocrinol; 2020 Aug; 65(2):1-10. PubMed ID: 32302969
[TBL] [Abstract] [Full Text] [Related]
6. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
[TBL] [Abstract] [Full Text] [Related]
7. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
[TBL] [Abstract] [Full Text] [Related]
8. Differences in Mutational Profile between Follicular thyroid Carcinoma and Follicular thyroid Adenoma Identified Using Next Generation Sequencing.
Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and Histologic Overlap and Distinction Among Various Hamartomatous Polyposis Syndromes.
Gilad O; Rosner G; Fliss-Isakov N; Aharon-Kaspi S; Strul H; Gluck N; Kariv R
Clin Transl Gastroenterol; 2019 May; 10(5):1-9. PubMed ID: 31107726
[TBL] [Abstract] [Full Text] [Related]
10. Loss of smad4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
Ritterhouse LL; Wu EY; Kim WG; Dillon DA; Hirsch MS; Sholl LM; Agoston AT; Setia N; Lauwers GY; Park DY; Srivastava A; Doyle LA
Histopathology; 2019 Oct; 75(4):546-551. PubMed ID: 31054158
[TBL] [Abstract] [Full Text] [Related]
11. A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.
Hayashi N; Kuroda Y; Saito T; Tsuruda Y; Niida A; Otsu H; Eguchi H; Masuda T; Suzuki Y; Natsugoe S; Mimori K
Surg Today; 2019 Sep; 49(9):738-747. PubMed ID: 30843125
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
13. Molecular Pathology of Anaplastic thyroid Carcinomas: A Retrospective Study of 144 Cases.
Bonhomme B; Godbert Y; Perot G; Al Ghuzlan A; Bardet S; Belleannée G; Crinière L; Do Cao C; Fouilloux G; Guyetant S; Kelly A; Leboulleux S; Buffet C; Leteurtre E; Michels JJ; Tissier F; Toubert ME; Wassef M; Pinard C; Hostein I; Soubeyran I
Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
[TBL] [Abstract] [Full Text] [Related]
14. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
[TBL] [Abstract] [Full Text] [Related]
15. smad4 gene promoter mutations in patients with thyroid tumors.
Nikolic A; Ristanovic M; Zivaljevic V; Rankov AD; Radojkovic D; Paunovic I
Exp Mol Pathol; 2015 Aug; 99(1):100-3. PubMed ID: 26079547
[TBL] [Abstract] [Full Text] [Related]
16. Effects of the smad4 C324Y mutation on thyroid cell proliferation.
D'Inzeo S; Nicolussi A; Nardi F; Coppa A
Int J Oncol; 2013 Jun; 42(6):1890-6. PubMed ID: 23591524
[TBL] [Abstract] [Full Text] [Related]
17. A complex endocrine conundrum.
Bano G; Siedel V; Beharry N; Wilson P; Cranston T; Hodgson S
Fam Cancer; 2013 Sep; 12(3):577-80. PubMed ID: 23242522
[TBL] [Abstract] [Full Text] [Related]
18. TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Cameselle-Teijeiro J; Soares P; Sobrinho-Simões M
Virchows Arch; 2012 Jun; 460(6):587-600. PubMed ID: 22527019
[TBL] [Abstract] [Full Text] [Related]
19. A novel human smad4 mutation is involved in papillary thyroid carcinoma progression.
D'Inzeo S; Nicolussi A; Donini CF; Zani M; Mancini P; Nardi F; Coppa A
Endocr Relat Cancer; 2012 Feb; 19(1):39-55. PubMed ID: 22109972
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing smad4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract] [Full Text] [Related]
[Next]
